Investment and research into the science of aging – and therapeutics that could slow down or even reverse the aging process – are ramping up. Past clinical failures have given way to new and focused approaches that aim to lengthen “healthspan,” turning the last years of life into the best years of life.
To read the full article click here.
2023 was a busy and productive year for Genflow Biosciences Plc (“Genflow) marked by significant advancements in our mission to pioneer novel therapeutics for a
We are thrilled to be named “a firm to watch” by The Guardian. Undoubtedly, the success of our NASH studies this past year and the
Health Tech World has announced its Top 50 health tech innovators of 2022
Headquarters
Genflow Biosciences plc
6 Heddon Street
London
W1B 4BT
United Kingdom
Research and Development
Genflow Biosciences SRL
Biopark Gosselies
Rue Clément Ader, 10
B-6041 Charleroi
Belgium
US office address
Genflow Biosciences Inc
1050 Connecticut Avenue
Suite 500
Washington DC
20036, USA